Back to search
FDAFDA · Food and drugs·Recall number D-1039-2016

tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057

Published June 29, 2016 · Recall initiated: May 11, 2016

Summary

FDA records drug Class II recall D-1039-2016, published June 29, 2016 and initiated May 11, 2016. Recalling firm: Profarma Distributors LLC; Status: Terminated; Reported quantity: 42 boxes (504 capsules); Lot: Lot # 224TS; Exp. 02/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Profarma Distributors LLC
Distributor
Nationwide
UPC
7501008485057
Lot
Lot # 224TS; Exp. 02/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057 recalled?

Yes. FDA published recall D-1039-2016 on June 29, 2016. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 7501008485057.